Use of an ultrashort-acting selective β1-adrenergic receptor antagonist esmolol in ear, nose and throat surgery
Abstract
Background / Aim: The concept of general balanced anaesthesia was devised in order to assure cardiovascular stability and fast post-anaesthesia recovery. This clinical trial was organised in order to investigate the parameters of cardiovascular function and emergence from anaesthesia in elective ear, nose and throat (ENT) surgery patients.
Methods: A total of 40 ASA I and II patients of both sexes scheduled for elective ENT surgery were randomly divided into two equal groups. Both groups received a continuous iv infusion of glucose 5 % solution and in the esmolol group this infusion also contained esmolol. Esmolol infusion rate was 0.3 mg/kg/min during the first 5 min and thereafter 0.1 mg/kg/min. In critical phases of anaesthesia and operation (induction, intubation, first incision, surgical manipulations, wound suture, extubation), systolic and diastolic blood pressure were monitored. Recovery after anaesthesia was assessed based on times of eye opening on command, spontaneous eye opening and regaining of full orientation. Increases in cardiovascular parameters by 20 % of the baseline values or more were treated with iv boluses of fentanyl, alone or with droperidol and, if necessary, by adding isoflurane 0.5 % to the inhalational mixture. Consumption of drugs was recorded.
Results: Esmolol assured stable values of cardiovascular parameters that were in most critical phases of anaesthesia and operation lower than in the control group. The duration of anaesthesia did not differ between the groups. In the esmolol group, lower consumption of fentanyl, droperidol and sevoflurane was registered. Patients in the esmolol group emerged from anaesthesia faster than patients in the control group.
Conclusion: Continuous iv infusion of esmolol assures better cardiovascular stability, necessitates lower consumption of analgesics and anaesthetics and results in faster emergence from general anaesthesia in elective ENT surgery.
References
Wolf AR. Effects of regional analgesia on stress responses to pediatric surgery. Paediatr Anaesth 2012 Jan;22(1):19-24.
Egan TD. Are opioids indispensable for general anaesthesia? Br J Anaesth 2019 Jun;122(6):e127-e135. doi: 10.1016/j.bja.2019.02.018.
Gorczynski RJ, Murthy VS, Hwang TF. Beta-blocking and hemodynamic effects of ASL-8052. J Cardiovasc Pharmacol 1984 Nov-Dec;6(6):1048-59.
Girard D, Shulman BJ, Thys DM, Mindich BP, Mikula SK, Kaplan JA. The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology 1986 Aug;65(2):157-64.
Harrison L, Ralley FE, Wynands E, Robbins GR, Sami M, Ripley R, et al. The role of an ultra short-acting adrenergic blocker (esmolol) in patients undergoing coronary artery bypass surgery. Anesthesiology 1987 Mar;66(3):413-8.
Lončar-Stojiljković D. Effects of esmolol infusion on cardiovascular parameters and quality of general anaesthesia in younger and older patients. Scr Med 2021 Jun;52(2):109-14.
Lončar-Stojiljković D. Effects of the ultra-short-acting beta-blocker esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery. Scr Med 2021 Sep;52(3):187-92.
Lončar-Stojiljković D, Maksimović ŽM, Djuric M. Esmolol as an adjunct to general balanced anaesthesia in neurosurgery. Scr Med 2021 Dec;52(4):279-83.
Srivastava U, Dupargude AB, Kumar D, Joshi K, Gupta A. Controlled hypotension for functional endoscopic sinus surgery: comparison of esmolol and nitroglycerine. Indian J Otolaryngol Head Neck Surg 2013 Aug;65 Suppl 2:S440-S444.
Kol IO, Kaygusuz K, Yildirim A, Dogan M, Gursoy S, Yucel E, Mimaroglu C. Controlled hypotension with desflurane combined with esmolol or dexmedetomidine during tympanoplasty in adults: a double-blind, randomized, controlled trial. Curr Ther Res 2009;70(3):197-208.
Shao H, Kuang LT, Hou WJ, Zhang T. Effect of desmopressin administration on intraoperative blood loss and quality of teh surgical field during functional endoscopic sinus surgery: a randomised, clinical trial. BMC Anesthesiology 2015;15:33. doi: 10.1186/s12871-015/0034/8.
Wiest D. Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics. Clin Pharmacokinet. 1995 Mar;28(3):190-202.
Cuneo BF, Zales VR, Blahunka PC, Benson DW Jr. Pharmacodynamics and pharmacokinetics of esmolol, a short-acting beta-blocking agent, in children. Pediatr Cardiol 1994 Nov-Dec;15(6):296-301.
Kurian SM, Evans R, Fernandes NO, Sherry KM. The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia 2001;56:1163-8.
Gupta S, Tank P. A comparative study of efficacy of esmolol and fentanyl for pressure attenuation during laryngoscopy and endotracheal intubation. Saudi J Anaesth 2011 Jan-Mar;5(1):2-8.
Maguire A, Thompson JP, Guest C, Sadler PJ, Strupish JW, West KJ. Comparison of the effects of intravenous alfentanil and esmolol on the cardiovascular response to double-lumen endobronchial intubation. Anaesthesia 2001;56:319-26.
Lee MH, Chung MH, Han CS, Lee JH, Choi YR, Choi EM, et al. Comparison of effects of intraoperative esmolol and ketamine infusion on acute postoperative pain after remifentanil-based anesthesia in patients undergoing laparoscopic cholecystectomy. Korean J Anesthesiol 2014 March;66(3):222-9.
Asouhidou I, Trikoupi A. Esmolol reduces anesthetic requirements thereby facilitating early extubation; a prospective controlled study in patients undergoing intracranial surgery. BMC Anesthesiology 2015 Nov 28;15:172. doi: 10.1186/s12871-015-0154-1.
Hamed JME, Ataalla WM. Esmolol infusion reduces blood loss and opiate consumption during fertility preserving myomectomy. Anest Essays Res 2019 Jul-Sep;13(3):423-9.
de Morais VBD, Sakata RK, Huang APS, da Cunha Ferraro LH. Randomized, double-blind, placebo-controlled study of the analgesic effect of intraoperative esmolol for laparoscopic gastroplasty. Acta Cir Bras 2020;35(4): e202000408. doi: 10.1590/s0102-865020200040000008.
Mendonca FT, Tramontini AJ, Miake HI, Seixas LF, de Carvalho LSF, Sposito AC. Intra-operative esmolol and pain following mastectomy: A randomised clinical trial. Eur J Anaesthesiol 2021 Jul 1;38(7):735-43.
Asouhidou I, Trikoupi A. Esmolol reduces anesthetic requirements thereby facilitating early extubation; a prospective controlled study in patients undergoing intracranial surgery. BMC Anesthesiology 2015 Nov 28;15:172. doi: 10.1186/s12871-015-0154-1.
Gruenbaum SE, Meng L, Bilotta F. Recent trends in the anesthetic management of craniotomy for supratentorial tumor resection. Curr Opin Anaesthesiol 2016 Oct;29(5):552-7.
Ornstein E, Young WL, Ostapkovich N, Matteo RS, Diaz J. Are all effects of esmolol equally rapid in onset? Anesth Analg 1995 Aug;81(2):297-300.
Srivastava VK, Agrawal S, Gautam SKS, Ahmed M, Sharma S, Kumar R. Comparative evaluation of esmolol and dexmedetomidine for attenuation of sympathomimetic response to laryngoscopy and intubation in neurosurgical patients. J Anaesthesiol Clin Pharmacol 2015 Apr-Jun;31(2):186-90.
Bebawy JF, Houston CC, Kosky JL, Badri AM, Hemmer LB, Moreland NC, et al. Nicardipine is superior to esmolol for the management of postcraniotomy emergence hypertension: a randomized open-label study. Anesth Analg 2015 Jan;120(1):186-92.
Guney A, Kaya FN, Yavascaoglu B, Gurbet A, Selmi NH, Kaya S, et al. Comparison of esmolol to nitroglycerine in controlling hypotension during nasal surgery. Eurasian J Med 2012 Aug;44(2):99-105.
Dogan SD, Ustun FE, Sener EB, Koksal E, Ustun YB, Kaya C, et al. Effects of lidocaine and esmolol infusions on hemodynamic changes, analgesic requirement, and recovery in laparoscopic cholecystectomy operations. Braz J Anesthesiol 2016;66(2):145-50.
Jangra K, Malhotra SK, Gupta A, Arora S. Comparison of quality of the surgical field after controlled hypotension using esmolol and magnesium sulfate during endoscopic sinus surgery. J Anaesthesiol Clin Pharmacol 2016 Jul-Sep;32(3):325-8.
Lavere PF, Rana NA, Kinsky MP, Funston JS, Mohamed SS, Chaaban MR. Clin Med Insights Ear Nose Throat 2019 May 10;12:1179550619847992. doi: 10.1177/1179550619847992.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).